Home-based up-dosing of wheat oral immunotherapy: Real-world effectiveness and predictive factor analysis
Asian Pacific Journal of Allergy and Immunology · 2025
DOI: 10.12932/ap-130224-1783 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asian Pacific Journal of Allergy and Immunology, 2025. Verfasst von Jiwon Kim und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Chungnam National University Sejong Hospital, Chungnam National University College of Medicine, Sejong, Korea. Hauptthemen laut MEDLINE: Wheat Hypersensitivity, Desensitization, Immunologic, Allergens, Triticum. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
BACKGROUND: Wheat allergy is one of the most prevalent allergens in Korea, decreasing quality of life and causing nutritional repercussions. OBJECTIVE: We aimed to investigate the efficacy and safety of the home-based wheat oral immunotherapy (OIT) using wheat noodles in children with a wheat allergy. METHODS: We conducted a retrospective study involving 72 children aged 3 to 17 years diagnosed with a wheat allergy. Patients received wheat OIT using wheat noodles (n = 50) and were compared with a historical control group (n = 22). Baseline characteristics, adverse events, and immunological changes were assessed. Predictors of successful desensitization were identified using logistic regression analysis. RESULTS: Among 50 patients completing the up-dosing phase, 82.0% achieved desensitization to 2,400 mg of wheat protein, compared to 4.5% in the control group (p < 0.001). During the up-dosing period, the median number of adverse reactions per person was 2, and anaphylaxis occurred in 30.0% (15/50). However, there were no life-threatening adverse events. In multivariable analysis, the presence of asthma (adjusted odds ratio [aOR], 8.88; 95% confidence interval [CI], 1.10-71.97; p = 0.041) and a higher ratio of specific IgE (sIgE) to ω-5-gliadin and total IgE (aOR 19.09, 95%CI 1.21-300.80, p = 0.036) were significantly associated with treatment outcomes of wheat OIT. CONCLUSION: Our study showed the safety and efficacy of home-based wheat OIT using boiled noodles in Korean children with wheat allergies. Careful consideration is warranted for patients with elevated baseline sIgE to ω-5-gliadin to total IgE ratio and a history of asthma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Chungnam National University Sejong Hospital, Chungnam National University College of Medicine, Sejong, Korea.
- Department of Pediatrics, Kosin University Gospel Hospital, Kosin University School of Medicine, Busan, Korea.
- Allergy Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
- Department of Pediatrics, Chung-Ang University Hospital, Seoul, Republic of Korea.
- Department of Pediatrics, Chuncheon Sacred Heart Hospital, Hallym University School of Medicine, Chuncheon, Korea.
- Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences & Technology, Seoul, Korea.
Zitieren
APA
Kim, J., Jung, M., Jang, S., Shin, S., Song, J., Kim, S., Kim, S., Lee, J. Y., Kim, H. M., Kim, Y., Lee, M. H., Lee, S. J., Kim, M., Kim, J., & Ahn, K. (2025). Home-based up-dosing of wheat oral immunotherapy: Real-world effectiveness and predictive factor analysis. Asian Pacific Journal of Allergy and Immunology. https://doi.org/10.12932/ap-130224-1783
Vancouver
Kim J, Jung M, Jang S, Shin S, Song J, Kim S, et al. Home-based up-dosing of wheat oral immunotherapy: Real-world effectiveness and predictive factor analysis. Asian Pacific Journal of Allergy and Immunology. 2025. doi:10.12932/ap-130224-1783
BibTeX
@article{Kim2025,
author = {Kim, Jiwon and Jung, Minyoung and Jang, Sehun and Shin, Sanghee and Song, Jeongmin and Kim, Sukyung and Kim, Sukyung and Lee, Ji Young and Kim, Hyun Mi and Kim, Yeonghee and Lee, Min Hee and Lee, Su Jin and Kim, Minji and Kim, Jihyun and Ahn, Kangmo},
title = {Home-based up-dosing of wheat oral immunotherapy: Real-world effectiveness and predictive factor analysis},
journal = {Asian Pacific Journal of Allergy and Immunology},
year = {2025},
doi = {10.12932/ap-130224-1783}
}
EUVIMED